Aditxt (ADTX) announced that its acquisition target, Evofem Biosciences (EVFM), has secured voting agreements with certain of its investors to ensure they will vote in favor of the merger proposal at Evofem’s upcoming Special Meeting of Stockholders.
Maximize Your Portfolio with Data Driven Insights:
- Leverage the power of TipRanks' Smart Score, a data-driven tool to help you uncover top performing stocks and make informed investment decisions.
- Monitor your stock picks and compare them to top Wall Street Analysts' recommendations with Your Smart Portfolio
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on ADTX:
- Aditxt, Inc. Focuses on Growth Amid Nasdaq Compliance
- Aditxt announces ‘positive’ FDA feedback for Appili Therapeutics ATI-1801
- Appili Therapeutics announces FDA alignment on ATI-1801 NDA requirements
- Aditxt Enters Major Investment Agreement with Evofem
- Aditxt CEO Clarifies NASDAQ Compliance and Capital Strategy